OA09023A - Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines. - Google Patents

Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.

Info

Publication number
OA09023A
OA09023A OA59487A OA59487A OA09023A OA 09023 A OA09023 A OA 09023A OA 59487 A OA59487 A OA 59487A OA 59487 A OA59487 A OA 59487A OA 09023 A OA09023 A OA 09023A
Authority
OA
OAPI
Prior art keywords
lactams
effects
intended
reduce
pharmaceutical composition
Prior art date
Application number
OA59487A
Other languages
English (en)
Inventor
Tancrede Cyrille
Andremont Antoine
Labia Roger
Leonard Florence
Original Assignee
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussy Inst Gustave filed Critical Roussy Inst Gustave
Publication of OA09023A publication Critical patent/OA09023A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
OA59487A 1987-04-10 1988-12-09 Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines. OA09023A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8705110A FR2613624B1 (fr) 1987-04-10 1987-04-10 Composition pharmaceutique, administrable par voie orale, destinee a reduire les effets des b-lactamines

Publications (1)

Publication Number Publication Date
OA09023A true OA09023A (fr) 1991-03-31

Family

ID=9350003

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59487A OA09023A (fr) 1987-04-10 1988-12-09 Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.

Country Status (8)

Country Link
EP (1) EP0309532A1 (fr)
JP (1) JPH01503537A (fr)
AU (1) AU604117B2 (fr)
FR (1) FR2613624B1 (fr)
OA (1) OA09023A (fr)
PT (1) PT87190B (fr)
WO (1) WO1988007865A1 (fr)
ZA (1) ZA882426B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
FR2843302B1 (fr) * 2002-08-09 2004-10-22 Centre Nat Rech Scient Forme galenique pour la delivrance colique de principes actifs
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FI20105572A0 (fi) 2010-05-24 2010-05-24 Prevab R Lcc Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
BR112016023360B1 (pt) 2014-04-17 2023-03-07 Synthetic Biologics, Inc Beta-lactamase e seu uso
JP6803328B2 (ja) 2014-08-28 2021-01-06 シンセティック バイオロジクス，インコーポレイテッド 大腸菌ベースでのベータラクタマーゼ生産
WO2016057744A1 (fr) 2014-10-08 2016-04-14 Synthetic Biologics, Inc. Formulations de bêta-lactamase et utilisations de celles-ci
EP3236993B1 (fr) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Méthodes et compositions pour inhiber ou prévenir les effets néfastes des antibiotiques oraux
EP3400953A1 (fr) 2014-12-23 2018-11-14 4D Pharma Research Limited Polypeptide pirin et modulation immunitaire
AR103260A1 (es) 2014-12-23 2017-04-26 4D Pharma Res Ltd Modulación inmunitaria
EP3261662B1 (fr) 2015-02-23 2021-07-21 Synthetic Biologics Inc. Carbapénémases à utiliser avec des antibiotiques pour la protection du microbiome intestinal
EP3265119B1 (fr) 2015-03-06 2023-10-11 Theriva Biologics, Inc. Dosage de beta-lactamase sûr et efficace pour la protection du microbiome
WO2016203221A1 (fr) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprenant des souches bactériennes
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SMT201900588T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ME03487B (fr) 2016-03-04 2020-01-20 4D Pharma Plc Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
EP3630942B1 (fr) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprenant des souches bactériennes
CA3066189A1 (fr) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprenant des souches bacteriennes
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici

Also Published As

Publication number Publication date
PT87190A (pt) 1988-05-01
EP0309532A1 (fr) 1989-04-05
PT87190B (pt) 1992-08-31
WO1988007865A1 (fr) 1988-10-20
FR2613624A1 (fr) 1988-10-14
ZA882426B (en) 1988-09-28
AU604117B2 (en) 1990-12-06
AU1578688A (en) 1988-11-04
FR2613624B1 (fr) 1990-11-23
JPH01503537A (ja) 1989-11-30

Similar Documents

Publication Publication Date Title
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
FR2523443B1 (fr) Nouvelles formulations pharmaceutiques contenant le coenzyme q10 adaptees pour l'administration topique
IE862554L (en) Pharmaceutical compositions
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
MX9203263A (es) Composicion farmaceutica analgesica para administracion nasal.
BE849632A (fr) Composition pharmaceutique pour l'administration orale
IT1210666B (it) Preparato farmaceutico ad assorbimento percutaneo per il trattamento di angina pectoris
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
FI903759A7 (fi) Oraalisesti annettava N-asetyyli-kysteiiniä sisältävä farmaseuttinen koostumus
IT8119673A0 (it) Composizioni farmaceutiche per il trattamento di osteopatie.
MA22443A1 (fr) Procede de preparation d'une composition pharmaceutique .
FI883673A7 (fi) Farmaceutiska kompositioner.
ATE90339T1 (de) Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel.
FI874414A7 (fi) Kontrolloidusti vapautuvia farmaseuttisiaainekokoomuksia.
IT8722031A0 (it) Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina.
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
OA06135A (fr) Composition pharmaceutique administrable par voie orale.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
OA08609A (fr) Composition pharmaceutique pour le traitement des infections bactériennes.
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.